HIV/AIDS drug costs "will be $4.4B/year"

24 June 2001

The United Nations has estimated that fighting the HIV/AIDS pandemic inthe world's poorest countries will soon cost $9.2 billion a year, with $4.4 billion going on treatment and $4.8 billion on prevention.

The estimates, which were published ahead of the UN special session on HIV/AIDS in New York, USA, on June 25-27 (see page 17), also estimated that the cost of antiretroviral drugs would take 12.5% of the total spend in the first year, rising to 25% of the total by 2005.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight